Patent · US Active

Systems and methods for continuous glucose monitoring outcome predictions

US12283381B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2024
Grant dateApr 22, 2025
Priority date
Expiry dateSep 20, 2044

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H10/60
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods and devices include predicting future glucose and engagement levels for a user by receiving the user's glucose levels collected by a continuous glucose monitoring (CGM) device over a time period, receiving engagement data associated with the user, wherein the engagement data are associated with the user's medication intake, diet, physical activity, laboratory results, and education activity, determining a first glycemia risk index (GRI) value, determining, using a machine learning model and responsive to the user's glucose levels and the engagement data collected over the time period, one or more predictions for future glucose levels for the user including a prediction that a future GRI value is greater than or less than the first GRI value, and determining, using the machine learning model and responsive to the user's engagement data collected over the time period, one or more predictions for future engagement levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.